scholarly journals Novel insight into MALAT-1 in cancer: Therapeutic targets and clinical applications

2016 ◽  
Vol 11 (3) ◽  
pp. 1621-1630 ◽  
Author(s):  
DANYANG REN ◽  
HUIYING LI ◽  
RENQIU LI ◽  
JIANMING SUN ◽  
PIN GUO ◽  
...  
Author(s):  
RAVINDER PAL SINGH ◽  
UMA BATRA

The use of artificial biomaterials has been acclaiming potential therapeutic scope in diverse clinical applications. This review started with the description of the basics of biomaterials, and desirable properties, which are the prerequisites to understand biomaterials. The orthopedic biomaterials, their classification and the importance of calcium phosphate (CaP) materials for hard-tissue applications were utterly discussed. Furthermore, among the various CaP biominerals, the importance of hydroxyapatite (HAP) and its synthesis techniques was comprehensively reviewed. The sol–gel route for the synthesis of HAP nanoparticles and deposition of coatings were systematically studied. Among the metallic substrates, Ti6Al4V alloy remained the focus of this study. Moreover, several film pre-preparation methods were also given due importance. The importance of other surface modification techniques, especially in the context of Ti6Al4V substrates, was also discussed. Among several coating techniques to deposit CaP coatings, special attention was paid to the spin and dip coating techniques. In addition to monolithic HAP coatings, reinforced and antimicrobial HAP coatings were also reviewed from broad perspectives. Therefore, this review provides an in-depth insight into the preparation and properties of apatitic nanoparticles and their coatings for orthopedic and dental applications.


2020 ◽  
Vol 11 (3) ◽  
pp. 303-303
Author(s):  
N.C. Rubas

The recently published article by P. Tsimaris et al. (2019) gave great prospective insight into non-traditional clinical applications of probiotic use as alternative and/or complementary therapeutics to traditional antibiotics for treatment of vulvovaginitis. However, these findings are too broad to be generalised as a treatment option for all women. The study design includes a cohort of Caucasian women and does not represent women of other ethnic groups.


Author(s):  
Chanie Wassner ◽  
Nicole Bradley ◽  
Yuman Lee

HIV is a serious chronic medical condition. Significant improvements in antiretroviral therapy have led to a transformation in its management. No curative treatment is available for HIV, and lifelong therapy is required with a combination of agents to control viral replication and prevent complications. Some of the older agents are notorious for many side effects, making patient compliance difficult, which is critical to preventing HIV resistance. Tenofovir is one of the newer, more tolerable, nucleotide reverse transcriptase inhibitors on the market; is a mainstay of many antiretroviral therapy combinations; and is now available in 2 different formulations, tenofovir disoproxil fumarate (TDF) and, the more recent, tenofovir alafenamide (TAF). These 2 formulations have very different pharmacokinetics, which seem to affect their efficacy and safety. This manuscript provides insight into the history of TDF and TAF development, their unique pharmacokinetics and pharmacology, clinically important adverse effects, monitoring, interactions, resistance, review of clinical studies, and guideline recommendations and clinical applications for tenofovir’s various indications.


2015 ◽  
Vol 62 (1) ◽  
pp. 31-38 ◽  
Author(s):  
Joseph A. Giovannitti ◽  
Sean M. Thoms ◽  
James J. Crawford

Abstract The α-2 adrenergic receptor agonists have been used for decades to treat common medical conditions such as hypertension; attention-deficit/hyperactivity disorder; various pain and panic disorders; symptoms of opioid, benzodiazepine, and alcohol withdrawal; and cigarette craving.1 However, in more recent years, these drugs have been used as adjuncts for sedation and to reduce anesthetic requirements. This review will provide an historical perspective of this drug class, an understanding of pharmacological mechanisms, and an insight into current applications in clinical anesthesiology.


Endocrinology ◽  
2019 ◽  
Vol 161 (1) ◽  
Author(s):  
Djurdjica Coss

Abstract Follicle-stimulating hormone (FSH) is a dimeric glycoprotein secreted by the anterior pituitary gonadotrope that is necessary for reproductive function in mammals. FSH primarily regulates granulosa cells and follicular growth in females, and Sertoli cell function in males. Since its identification in the 1930s and sequencing in the 1970s, significant progress has been made in elucidating its regulation and downstream function. Recent advances provide deeper insight into FSH synthesis, and effects in the gonads suggest potential roles in extragonadal tissues and examine pharmacological approaches and clinical applications in infertility treatment that now affect 18% of couples. These advances were discussed in detail in a number of reviews published in the last 2 years in Endocrinology. In this brief commentary, we summarize these reviews and point to the outstanding questions that should be answered in the near future to bridge a gap in our understanding of this hormone.


2021 ◽  
Vol 14 ◽  
Author(s):  
Jiurong Cheng ◽  
Yingdong Deng ◽  
Jun Zhou

As a significant public health issue, chronic pain, mainly neuropathic pain (NP) and inflammatory pain, has a severe impact. The underlying mechanisms of chronic pain are enigmatic at present. The roles of ubiquitin have been demonstrated in various physiological and pathological conditions and underscore its potential as therapeutic targets. The dysfunction of the component of the ubiquitin system that occurs during chronic pain is rapidly being discovered. These results provide insight into potential molecular mechanisms of chronic pain. Chronic pain is regulated by ubiquitination, SUMOylation, ubiquitin ligase, and deubiquitinating enzyme (DUB), etc. Insight into the mechanism of the ubiquitin system regulating chronic pain might contribute to relevant therapeutic targets and the development of novel analgesics.


10.4081/73 ◽  
2011 ◽  
Vol 3 (1) ◽  
Author(s):  
Ana Margarida Abrantes ◽  
Maria Elisa Serra ◽  
Dina Murtinho ◽  
Antonio Rocha Gonsalves ◽  
Maria Filomena Botelho

Sign in / Sign up

Export Citation Format

Share Document